Wire2026 05 03Fda Expanding Access To Pancreatic Cancer Drug To Some Patients
1 outlet

FDA expanding access to pancreatic cancer drug to some patients

The FDA this week announced it would be expanding access to a promising pancreatic cancer drug that nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial.

First seen · 5:23 PM UTCMay 3, 2026

How it's being covered

Methodology →
LeftCenterRight
0Left · 0%1Center-Left · 100%0Center · 0%0Center-Right · 0%0Right · 0%

Covering this story

Sorted left → right

Also happening today

All today →

Also on this date in history

All →